Article
Segment 7: Comparing Known Adverse Events of HCV Drugs
A recent report from Adverse Events suggests that based on the pre-approval adverse events listed for Viekira Pak that Harvoni and Sovaldi may be safer, according to Keith Hoffman, Phd.
A recent report from Adverse Events suggests that based on the pre-approval adverse events listed for Viekira Pak that Harvoni and Sovaldi may be safer, according to Keith Hoffman, Phd.
However, the company plans to monitor what happens post-marketing with all 3 drugs to determine their true safety profiles. He added that Express Scripts’ adherence guarantee for Viekira Pak is encouraging because that is one of the concerns of choosing Viekira Pak over Harvoni.
“I think there’s going to be some interesting post-marketing adverse events that will cause separation in some of these drugs,” Dr Hoffman added.
